References
- Quiding H, Anderson P, Bondesson U, Boréus LO, Hynning PA. (1986). Plasma concentrations of codeine and its metabolite, morphine, after single and repeated oral administration. Eur j Clin Pharmacol, 30:673–677.
- Nürnberg E, Surmann P. (1991). Hagers Handbuch der Pharmazeutischen Praxis, Methoden. Berlin, Heidelberg, New York: Springer Verlag.
- Roblegg E, Dittrich P, Haltmeyer K et al. (2010). Reformulation of a codeine phosphate liquid controlled release product. Drug Dev Ind Jun 10. [In press].
- Aylward M, Maddock J, Davies DE, Protheroe DA, Leideman T. (1984). Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur j Respir Dis, 65:283–291.
- Guay DR, Awni WM, Halstenson CE, Findlay JW, Opsahl JA, Abraham PA et al. (1987). Pharmacokinetics of codeine after single- and multiple-oral-dose administration to normal volunteers. J Clin Pharmacol, 27:983–987.
- Yue QY, Hasselström J, Svensson JO, Säwe J. (1991). Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine. Br J Clin Pharmacol, 31:635–642.
- Vree TB, Verwey-van Wissen CP. (1992). Pharmacokinetics and metabolism of codeine in humans. Biopharm Drug Dispos, 13:445–460.
- Hanses A, Spahn-Langguth H, Meiss F, Mutschler E. (1996). Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration. Arzneimittelforschung, 46:57–63.
- Poulsen L, Brøsen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. (1996). Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharmacol, 51:289–295.
- Laneury JP, Duchene P, Hirt P, Delarue A, Gleizes S, Houin G et al. (1998). Comparative bioavailability study of codeine and ibuprofen after administration of the two products alone or in association to 24 healthy volunteers. Eur J Drug Metab Pharmacokinet, 23:185–189.
- Kronstrand R, Jones AW. (2001). Concentration ratios of codeine-to-morphine in plasma after a single oral dose (100 mg) of codeine phosphate. J Anal Toxicol, 25:486–487.
- Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE Jr, Cone EJ et al. (2002). Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem, 48:1486–1496.
- Band CJ, Band PR, Deschamps M, Besner JG, Coldman AJ. (1994). Human pharmacokinetic study of immediate-release (codeine phosphate) and sustained-release (codeine Contin) codeine. J Clin Pharmacol, 34:938–943.
- Zeng HX, Cheng G, Pan WS, Zhong GP, Huang M. (2007). Preparation of codeine-resinate and chlorpheniramine-resinate sustained-release suspension and its pharmacokinetic evaluation in beagle dogs. Drug Dev Ind Pharm, 33:649–665.
- Langenbucher F. (1982). Numerical convolution/deconvolution as a tool for correlating in vitro with in vivo drug availability. Pharm Ind, 44:1166–1172.
- Kogan MD, Pappas G, Yu SM, Kotelchuck M. (1994). Over-the-counter medication use among US preschool-age children. Jama, 272:1025–1030.